AR and prostate carcinoma: In CWR22 AR‐positive prostate cancer cells, ENZ treatment strongly correlated with gene sets associated with OXPHOS, mitochondrial aerobic respiration, and respiratory electron transport chain (Figure 2A), suggesting potential metabolic vulnerabilities that might influence ENZ sensitivity.